Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532. [electronic resource]
Producer: 20190715Description: 254-261 p. digitalISSN:- 1527-7755
- Adolescent
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers, Tumor -- genetics
- Chemoradiotherapy, Adjuvant -- adverse effects
- Child
- Child, Preschool
- Chromosomes, Human, Pair 1
- Chromosomes, Human, Pair 16
- Dactinomycin -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Genetic Predisposition to Disease
- Humans
- Infant
- Kidney Neoplasms -- genetics
- Loss of Heterozygosity
- Lymph Nodes -- pathology
- Lymphatic Metastasis
- Male
- Neoplasm Staging
- Nephrectomy
- Phenotype
- Progression-Free Survival
- Prospective Studies
- Radiation Dosage
- Risk Factors
- Time Factors
- Vincristine -- administration & dosage
- Wilms Tumor -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.